28. September 2023
Pava Partners advises Ardian and GBA Group on the acquisition of ICCR-Roßdorf
Pava Partners advised Ardian and its portfolio company GBA Group on the acquisition of ICCR-Roßdorf GmbH (Institute for Competence Contract Research – Roßdorf, in short ICCR-Roßdorf). With this acquisition, GBA Group is expanding its range of toxicology services for national and international customers in the chemical, medical device and pharmaceutical industries.
ICCR-Roßdorf has been on the market for 30 years and is one of the world’s leading Gentox suppliers. Their focus is on investigating the genotoxic potential of pharmaceuticals, agrochemicals, cosmetics and chemicals. It employs around 100 people and is based in Roßdorf near Darmstadt.
With this acquisition, GBA Group demonstrates its ambition to position itself broadly as an international life science service provider through targeted portfolio expansions and investments in leading CROs: It strengthens its growth in the preclinical area and, through the now closer collaboration, reinforces the joint development of innovative assays in new application areas.
“ICCR-Roßdorf is a perfect complement to GBA’s life sciences activities. The acquisition will enable GBA to provide a strong offering of preclinical phase (genetic) toxicology analyses to its global customer base. It also expands the service portfolio for GBA’s medical technology customers and strengthens its agricultural science business. The excellent and efficient cooperation with Pava Partners enabled us to close this transaction quickly and in close cooperation with the seller,” said Dr. Alexander Friedrich, Managing Director of Ardian Buyout.
Ardian is a leading global private investment firm, managing or advising $150 billion in assets on behalf of more than 1,470 clients worldwide. Our extensive expertise in private equity, real assets and credit enables us to offer a broad range of investment opportunities and to respond flexibly to the diverse needs of our clients. Through Ardian Customized Solutions, we create customized portfolios that allow institutional clients to determine the mix of assets they want and access funds managed by leading third-party providers. Private Wealth Solutions provides specialized services and access solutions to private banks, family offices and private institutional investors worldwide. Ardian’s most important shareholder group is its employees, and we place great emphasis on developing our people and fostering a collaborative culture based on collective intelligence. Our more than 1,050 employees in 16 offices across Europe, the Americas, Asia and the Middle East are committed to the principles of responsible investing and determined to make finance a force for good in society. Our goal is to achieve excellent investment performance combined with high ethical standards and social responsibility.
At Ardian, we invest everything in building businesses that last.
GBA Group is an international life science service company with more than 2,000 employees and a wide range of analytical, logistical and specialist services in the fields of pharmaceuticals, medical devices, cosmetics, chemicals, food, drinking water and the environment.
The range of services includes laboratory analytics, data management, special logistical services in the field of clinical trials, and consulting for private companies and public institutions in connection with their activities in the fields of research, product development, market development, and consumer protection.
With its services, the GBA Group makes a sustainable contribution to health, the environment and society. GBA Group operates sites in Austria, Belgium, Finland, France, Germany, Poland, Spain and the United States.
ICCR-Roßdorf GmbH, located in Roßdorf near Darmstadt, is one of the leading contract toxicology laboratories in Germany and offers GLP-compliant studies to its customers on an international level. Accreditation under EN ISO 17025 makes us a reliable partner also for toxicological testing of medical devices. We also perform biological efficacy testing under GMP for our customers in the pharmaceutical industry. For more than 30 years, we have been committed to providing our customers with customized solutions at the highest scientific level.
